For the prognosis of bipolar disorder[1]: Many people with bipolar disorder have successful good treatment, which, in turn, results from an accurate diagnosis. Because bipolar disorder may have a high rate of both under-diagnosis and diagnosis wrong, it is often difficult for people with the condition to receive competent treatment. Patients with bipolar disorder are… Read More »
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women’s Mental Health at Massachusetts General Hospital, recently shared his insights on mitigating psychiatric relapse during pregnancy amidst the COVID-19 pandemic with Ob.Gyn News on August 28th, 2020 In a previous column, I addressed some of the issues that quickly arose in the context of the… Read More »
To improve standardization of headache disorder diagnoses, the International Classification of Headache Disorders (ICHD) was created and consists of chapters on primary headache disorders, secondary headache disorders, and painful cranial neuralgias/facial pain. However, the clinical application of the ICHD may be challenging for physicians who are inexperienced in headache medicine, the researchers noted. Neurophysiological tests,… Read More »
FDA Approves Uplizna (inebilizumab-cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) Print this page GAITHERSBURG, Md., June 11, 2020 (GLOBE NEWSWIRE) — Viela Bio (Nasdaq:VIE) today announced that the U.S. Food and Drug Administration (FDA) has approved Uplizna (inebilizumab-cdon) for the treatment of adult patients with neuromyelitis optica spectrum disorder (NMOSD) who are… Read More »